Russian Journal of Infection and ImmunityRussian Journal of Infection and Immunity2220-76192313-7398SPb RAACI17110.15789/2220-7619-2014-2-GENITAL WARTS INCIDENCE IN SAINT-PETERBURG, LENINGRADSKAYA REGION, KARELIYA REPUBLIC IN 2004–2013StebelkoO. Yu.<p>Researcher, Laboratory of epidemiology</p>197101, Russian Federation, St. Petersburg, Mira str., 14<p> </p>stebelkoou@rambler.ruGayvoronskayaO. V.Head of the Organizational-Methodological Departmentstebelkoou@rambler.ruKasatkinE. V.General Medical Managerstebelkoou@rambler.ruKatkyavicheneE. V.PhD (Medicine), Dermatovenereologiststebelkoou@rambler.ruEgorovaYu. S.General Medical Managerstebelkoou@rambler.ruSt. Petersburg Pasteur Institute, St. PetersburgUrban Dermatovenerologic dispensary, St. PetersburgDermatovenerologic dispensary No. 8, St. PetersburgRepublican Skin and Venereal Diseases Dispensary, PetrozavodskLeningrad Regional Center, Leningrad region10072014421871911007201410072014Copyright © 2014, Stebelko O.Y., Gayvoronskaya O.V., Kasatkin E.V., Katkyavichene E.V., Egorova Y.S.2014<p><strong>Abstract.</strong> In 2012, information on vaccination against human papillomavirus infection was included in the form of state statistics number 5 «Information on vaccinations» in according to the Order of Rosstat number 645. In the world practice, as one of the early performance criteria of effectiveness of immunization against human papilloma virus is morbidity rate by anogenital warts. The aim of this study was to investigate the regional characteristics of distribution of anogenital (venereal) warts before and in the initial periods of vaccination against human papillomavirus infection in three regions of the North-West Federal Regions — Saint Petersburg, Leningrad Oblast, Republic of Karelia. The period of retrospective epidemiological analysis was 10 years. There were significant differences in the levels and trends, morbidity by anogenital warts in general population and by gender. Moreover, different patterns of the frequency of disease among household contacts were revealed. In all three areas persons of 18–29 years old were identified as the risk group. The importance of determining the characteristics of epidemic processes for specified nosology in each territory has been demonstrated.</p>Incidence of genital wartsvaccination against papillomavirusзаболеваемость аногенитальными (венерическими) бородавкамивакцинация против ВПЧ[1. Вакцины для профилактики рака шейки матки / Под ред.П.Л. Стерна, Г.С. Китченера; пер. с англ.; под общ. ред. акад. РАМН Г.Т. Сухих, проф. В.Н. Прилепской. — М.: МЕДпресс-информ, 2009. — 192 с. Vaktsiny dlya profilaktiki raka sheyki matki (pod red.P.L. Sterna, G.S. Kitchenera; per. s angl.; pod obshch. red. akad. RAMN G.T. Sukhikh, prof. V.N. Prilepskoy) [Vaccines for the prevention of cervical cancer (eds. P.L. Stern, G.S. Kitchener; general eds. G.T. Sukhikh, V.N. Prilepskaya)]. Moscow: MEDpress-inform, 2009, 192 p.][2. Лялина Л.В., Касаткин Е.В., Стебелько О.Ю. Папилломавирусная инфекция и рак (этиология, эпидемиология, вакцинопрофилактика): учебное пособие. — СПб.: Изд-во СЗГМУ им. И.И. Мечникова, 2013. — 88 с. Lyalina L.V., Kasatkin E.V., Stebel`ko O.Yu. Papillomavirusnaya infektsiya i rak (etiologiya, epidemiologiya, vaktsinoprofilaktika): uchebnoe posobie [Human papillomavirus infection and cancer (etiology, epidemiology, vaccination)]. St. Petersburg, SZGMU named after I.I. Mechnikov, 2013, 88 p.][3. Сухих Г.Т., Прилепская В.Н. Профилактика рака шейки матки. — М.: МЕДпресс-информ, 2012. — 192 с. Sukhikh G.T., Prilepskaya V.N. Profilaktika raka sheyki matki [Cervical Cancer Prevention]. Moscow, Medpress-inform, 2009, 192 p.][4. Patel H., Wagner M., Singhal P., Kothari S. Systematic review of the incidence and prevalence of genital warts. BMN Infectious Diseases, 2013 http://www.biomedcentral.com/1471-2334/13/39.][5. Dinh T., Sternberg M., Dunne E.F., Markowitz L.E. Genital warts among 18- to 59-year-olds in the United States, National Health and Nutrition Examination Survey, 1999–2004. Sex. Transm. Dis., 2008, vol. 35, no. 4, pp. 357–360.][6. Leval A., Herweijer E., Arnheim-Dahlström L., Walum H., Frans E., Sparén P., Simard J.F. Incidence of genital warts in Sweden before and after quadrivalent Human papillomavirus vaccine availability. J. Infect. Dis., 2012, pp. 860–866.][7. Kraut A.A., Schink T., Schulze-Rath R., Mikolajczyk R.T., Garbe E. Incidence of genital warts in Germany: a population-based cohort study. BMC Infectious Diseases, 2010, vol. 10. Accessed on: http://www.biomedcentral.com/1471-2334/10/360.]